Renovo wins European Biotechnica Award

Renovo Group plc (LSE: RNVO), the biopharmaceutical company developing drugs for the prevention and reduction of scarring at multiple body sites, is pleased to announce that it has won first prize in the final round of the European Biotechnica Award 2007. This was the first time that the award has been won by a UK biotech company.

The award, which brings with it benefits worth up to 100,000 Euros, is presented by the Deutsche Messe AG to European biotech and life science companies in related fields. The international jury, which was made up of distinguished biotech experts from six countries, selected the winner from a list of 27 applicants. The major criteria in the selection of the award winners were the marketability, relevance and impact of the products under consideration and the existence of a potentially successful marketing concept and strategy.

Christian Wulff, the Premier of Lower Saxony, Dr. Karl-Ludwig Kley, Chairman of the Board of Merck KGaA, Christian Siebert, departmental head at the European Commission, and Stephan Ph. Kühne, who sits on the Board of Management at Deutsche Messe AG, Hannover, presented the prizes in the presence of more than 500 invited people from the worlds of science, business and politics.

Professor Mark W J Ferguson, Chief Executive Officer of Renovo, said:

"We are delighted to be the first UK biotech company to win the European Biotechnica Award. This highly prestigious award, which was judged by an international jury of biotech experts, is further recognition of the strength of Renovo's research and development expertise, its product pipeline, and the huge potential market for drugs targeted at the prevention and reduction of scarring."

Professor Dr. Peter J. W. Stadler in his capacity as jury chairman, said:

"The winner Renovo impressed the jury with its high scientific standards, its pioneering products in a very important area of application that has hitherto suffered from low standards of treatment, its strong financial situation and its genuine entrepreneurial spirit."

^Back to Top